Position
D. E. Shaw & Co., Inc. in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$7.02M$46.30 → $33.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 653.9K | $30.3M | — | — | — | 0.0% |
| Q1 2026 | 530.7K | $17.6M | $33.07 | −$7.02M | −$5.7M | 0.0% |